Targeting mitochondrial homeostasis as a cancer treatment strategy: current status and future prospects

Area of Science:

• Mitochondrial biology
• Cancer research
• Metabolic reprogramming

Background:

• Mitochondria play a crucial role in cellular metabolism and homeostasis.
• Mitochondrial dysfunction is implicated in the development and progression of various diseases, including cancer.
• Cancer cells exhibit metabolic reprogramming, impaired mitochondrial quality control, and DNA damage, contributing to tumor growth and metastasis.

Purpose of the Study:

• To review the intricate relationship between mitochondrial dysfunction and cancer.
• To explore the roles of metabolism, quality control, DNA stability, ion homeostasis, and the tumor microenvironment in cancer.
• To update on current mitochondria-targeted therapies and identify translational gaps.

Main Methods:

• Literature review
• Synthesis of current research on mitochondria and cancer
• Analysis of therapeutic strategies and future directions

Main Results:

• Mitochondrial dysfunction is a key driver in cancer initiation, development, and metastasis.
• Metabolic reprogramming, impaired mitochondrial quality control, and DNA damage are hallmarks of cancer cells.
• Dysfunctional mitochondria in tumor-infiltrating immune cells, like CD8+ T cells, promote cancer progression.
• Mitochondria-targeted therapies show promise but face translational challenges.

Conclusions:

• Mitochondrial homeostasis is a critical target for effective cancer therapy.
• Restoring mitochondrial function holds potential for improving therapeutic outcomes in cancer treatment.
• Further research is needed to bridge the gap between bench discoveries and clinical applications for mitochondria-targeted cancer therapies.